US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac S4 faces hurdles like cost, availability & low acceptance.
Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.
Nitric oxide used in nasal spray prevents SARS-CoV-2 from spreading to the lungs and can stop replication of the virus, finds study by researchers affiliated with makers of FabiSpray.
Nasal vaccines and sprays have been subject of discussion since early days of Covid, with research finally making headway into actually testing them for mucosal immunity.
The development of mucosal vaccines for Covid has been spurred on by the success of the oral polio vaccine, which induces 'mucosal immunity' in the gut.
The collusion between the new class of bureaucrats, politicians, businessmen and trade union bosses perpetuates itself partly because of the short-run benefits and partly because they see no way out of the system, wrote author MH Mody in 1980.
IAF is firming up plans to revamp airlift capabilities with medium transport aircraft that will be assembled in India & serve as its main workhorse. Embraer is leading contender as of now.
COMMENTS